XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Stockholders' Equity          
Stock-based compensation expense $ 7,069 $ 7,112 $ 21,486 $ 21,528  
RSU          
Stockholders' Equity          
Unrecognized compensation cost $ 15,600   $ 15,600    
Weighted-average period     2 years 2 months 12 days    
Shares          
Nonvested at the beginning of the period (in shares)     455,515    
Granted (in shares)     333,001    
Vested (in shares)     (389,042)    
Forfeited (in shares)     (5,253)    
Nonvested at the end of the period (in shares) 394,221   394,221    
Weighted-Average Fair Value          
Nonvested at the beginning of the period (in dollars per share)     $ 85.15    
Granted (in dollars per share)     95.41    
Vested (in dollars per share)     79.75    
Forfeited (in dollars per share)     84.59    
Nonvested at the end of the period (in dollars per share) $ 99.16   $ 99.16    
Stock Options          
Stockholders' Equity          
Unrecognized compensation cost $ 1,000   $ 1,000    
Weighted-average period     2 years 2 months 12 days    
Number of Options          
Outstanding at the beginning of the period (in shares)     83,677    
Granted (in shares)     22,438    
Exercised (in shares)     (16,767)    
Expired or forfeited (in shares)     (4,375)    
Outstanding at the end of the period (in shares) 84,973   84,973    
Exercisable at the end of the period (in shares) 40,578   40,578    
Weighted Average Exercise Price          
Outstanding at the beginning of the period (in dollars per share)     $ 87.09    
Granted (in dollars per share)     119.45    
Exercised (in dollars per share)     82.90    
Expired or forfeited (in dollars per share)     86.09    
Outstanding at the end of the period (in dollars per share) $ 96.51   $ 96.51    
Weighted-Average Remaining Contractual Term          
Outstanding at the end of the period     7 years 6 months    
Exercisable at the end of the period     5 years 9 months 18 days    
Aggregate Intrinsic Value          
Outstanding at the end of the period $ 3,935   $ 3,935    
Exercisable at the end of the period $ 2,264   $ 2,264    
Performance-based restricted stock units          
Shares          
Granted (in shares)     75,988 110,811  
Performance-based restricted stock units | Minimum          
Shares          
Share based compensation arrangement by percentage of shares units awarded     0.00%    
Performance-based restricted stock units | Maximum          
Shares          
Share based compensation arrangement by percentage of shares units awarded     376.00%    
OSI Plans          
Stockholders' Equity          
Shareholders approved increased the shares under OSI Plan         2,400,000
Shares available for grant 2,500,000   2,500,000    
OSI Plans | RSU          
Stockholders' Equity          
Number of shares available for grant reduced for each award granted     1.87    
Number of shares available for grant increased for each award forfeited and returned     1.87    
Cost of goods sold          
Stockholders' Equity          
Stock-based compensation expense $ 214 229 $ 701 $ 686  
Selling, general and administrative          
Stockholders' Equity          
Stock-based compensation expense 6,650 6,757 20,326 20,467  
Research and development          
Stockholders' Equity          
Stock-based compensation expense $ 205 $ 126 $ 459 $ 375